BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38759975)

  • 1. Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.
    Guillet B; Pawlowski M; Boisseau P; Répessé Y; Beurrier P; Bayart S; Delavenne X; Trossaërt M; Lenting PJ
    Thromb Haemost; 2024 Jun; ():. PubMed ID: 38759975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.
    Stoof SC; Sanders YV; Petrij F; Cnossen MH; de Maat MP; Leebeek FW; Kruip MJ
    Thromb Haemost; 2013 Mar; 109(3):440-9. PubMed ID: 23348756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.
    Castaman G; Mancuso ME; Giacomelli SH; Tosetto A; Santagostino E; Mannucci PM; Rodeghiero F
    J Thromb Haemost; 2009 Nov; 7(11):1824-31. PubMed ID: 19719828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A.
    Shu M; Malcolmson C; Bouskill V; Stain AM; Wakefield C; Blanchette VS; Carcao MD
    Haemophilia; 2024 Jan; 30(1):116-122. PubMed ID: 38037243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant manner.
    Loomans JI; Stokhuijzen E; Peters M; Fijnvandraat K
    J Clin Transl Res; 2018 Jul; 3(Suppl 2):351-357. PubMed ID: 30873482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDAVP challenge tests in boys with mild/moderate haemophilia A.
    Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
    Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
    Mansouritorghabeh H; Shirdel A
    J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4
    Gunasekera D; Vir P; Karim AF; Ragni MV; Pratt KP
    Front Immunol; 2023; 14():1128641. PubMed ID: 36936969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
    Chao BN; Baldwin WH; Healey JF; Parker ET; Shafer-Weaver K; Cox C; Jiang P; Kanellopoulou C; Lollar P; Meeks SL; Lenardo MJ
    J Thromb Haemost; 2016 Feb; 14(2):346-55. PubMed ID: 26588198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation.
    Radic CP; Rossetti LC; Abelleyro MM; Tetzlaff T; Candela M; Neme D; Sciuccati G; Bonduel M; Medina-Acosta E; Larripa IB; de Tezanos Pinto M; De Brasi CD
    J Thromb Haemost; 2015 Apr; 13(4):530-9. PubMed ID: 25611311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
    Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
    Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.
    Hews-Girard J; Rydz N; Lee A; Goodyear MD; Poon MC
    Haemophilia; 2018 Sep; 24(5):720-725. PubMed ID: 30004154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction model.
    Rode F; Almholt K; Petersen M; Kreilgaard M; Kjalke M; Karpf DM; Groth AV; Johansen PB; Larsen LF; Loftager M; Haaning J
    J Thromb Haemost; 2018 Jun; 16(6):1141-1152. PubMed ID: 29582559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice.
    Romano LGR; Schütte LM; van Hest RM; Meijer K; Laros-van Gorkom BAP; Nieuwenhuizen L; Eikenboom J; Heubel-Moenen FCJI; Uitslager N; Coppens M; Fijnvandraat K; Driessens MHE; Polinder S; Cnossen MH; Leebeek FWG; Mathôt RAA; Kruip MJHA;
    Res Pract Thromb Haemost; 2024 Mar; 8(3):102367. PubMed ID: 38660455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and determinants of response to treatment with desmopressin in mild hemophilia a.
    Di Perna C; Riccardi F; Franchini M; Rivolta GF; Pattacini C; Tagliaferri A
    Semin Thromb Hemost; 2013 Oct; 39(7):732-9. PubMed ID: 24030345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
    J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged α-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R.
    Miyashita R; Shinozawa K; Inaba H; Amano K; Kinai E
    Int J Hematol; 2022 Oct; 116(4):489-499. PubMed ID: 35590009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding.
    Candy V; Whitworth H; Grabell J; Thibeault L; Harpell L; Bowman M; Good D; Hopman WM; Sidonio RF; James PD
    Blood Adv; 2018 Oct; 2(20):2629-2636. PubMed ID: 30327371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Deletion Mutation of the F8 Gene for Hemophilia A.
    Wang J; Gu J; Chen H; Wu Q; Xiong L; Qiao B; Zhang Y; Xiao H; Tong Y
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.